Accredited Investors Inc. Eli Lilly & CO Transaction History

Accredited Investors Inc.

$1.55 Billion
Q2 2024

A detailed history of Accredited Investors Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Accredited Investors Inc. holds 3,218 shares of LLY stock, worth $2.9 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

3,218

Previous 3,254 1.11%

Holding current value

$2.9 Million

Previous $2.53 Million 15.09%

% of portfolio

0.19%

Previous 0.17%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $26,095 - $32,725	-36 Reduced 1.11%	3,218 $2.91 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $99,489 - $133,103	168 Added 5.44%	3,254 $2.53 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $10,503 - $12,382	-20 Reduced 0.64%	3,086 $1.8 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $1.35 Million - $1.86 Million	3,106 New	3,106 $1.67 Million
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $1,553 - $1,824	5 Added 0.17%	2,999 $1.03 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $8,681 - $10,116	-27 Reduced 0.89%	2,994 $1.1 Million
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $24,904 - $28,381	84 Added 2.86%	3,021 $977,000
Q2 2022 Jul 21, 2022	SELL	$278.73 - $327.27 $2,229 - $2,618	-8 Reduced 0.27%	2,937 $952,000
Q1 2022 May 06, 2022	BUY	$234.69 - $291.66 $1,877 - $2,333	8 Added 0.27%	2,945 $843,000
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $31,703 - $39,344	-141 Reduced 4.58%	2,937 $811,000
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $23,268 - $28,634	105 Added 3.53%	3,078 $711,000
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $1,444 - $1,868	8 Added 0.27%	2,973 $682,000
Q1 2021 Apr 16, 2021	SELL	$164.32 - $212.72 $35,328 - $45,734	-215 Reduced 6.76%	2,965 $554,000
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $19,047 - $25,203	146 Added 4.81%	3,180 $537,000
Q3 2020 Nov 05, 2020	SELL	$146.22 - $169.13 $731 - $845	-5 Reduced 0.16%	3,034 $449,000
Q2 2020 Jul 29, 2020	BUY	$136.42 - $164.18 $954 - $1,149	7 Added 0.23%	3,039 $499,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $952 - $1,178	8 Added 0.26%	3,032 $421,000
Q4 2019 Jan 23, 2020	SELL	$106.92 - $132.43 $17,748 - $21,983	-166 Reduced 5.2%	3,024 $397,000
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $7,795 - $8,479	73 Added 2.34%	3,190 $357,000
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $22,601 - $26,381	204 Added 7.0%	3,117 $0
Q1 2019 Apr 17, 2019	BUY	$111.31 - $131.02 $7,680 - $9,040	69 Added 2.43%	2,913 $378,000
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $12,496 - $13,999	-118 Reduced 3.98%	2,844 $329,000
Q3 2018 Oct 23, 2018	BUY	$85.86 - $107.31 $858 - $1,073	10 Added 0.34%	2,962 $318,000
Q2 2018 Jul 31, 2018	BUY	$75.7 - $86.88 $8,856 - $10,164	117 Added 4.13%	2,952 $252,000
Q1 2018 Apr 18, 2018	BUY	$74.21 - $87.6 $1,484 - $1,752	20 Added 0.71%	2,835 $219,000
Q4 2017 Jan 17, 2018	SELL	$81.94 - $87.89 $10,406 - $11,162	-127 Reduced 4.32%	2,815 $238,000
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $226,739 - $251,658	2,942	2,942 $252,000

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Accredited Investors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Accredited Investors Inc. with notifications on news.

Account

Accredited Investors Inc. Eli Lilly & CO Transaction History